Gentamicin uptake and killing were studied in aminoglycoside-susceptible wildtype Staphylococcus aureus strains and aminoglycoside-resistant small-colony mutants selected by gentamicin from these strains. In wild-type S. aureus three phases of gentamicin accumulation were noted, and killing occurred during the last and most rapid phase of uptake. Uptake and killing were abolished by anaerobic growth and sodium azide, suggesting that energy-dependent active drug transport required respiration. Treatment ofwild-type strains with the uncouplers N,N'-dicyclohexyl carbodiimide (DCCD) and carbonyl cyanide-m-chlorophenyl hydrazone showed disparate effects on gentamicin uptake, producing enhanced and diminished accumulations, respectively. Small-colony mutants demonstrated markedly deficient uptake compared with the wild-type strains and were not killed by gentamicin in concentrations up to 10 ,Lg/ml. Several classes of aminoglycoside-resistant mutant strains are described. One mutant strain was a menadione auxotroph which, when grown in the presence of menadione, exhibited normal gentamicin uptake and killing. Gentamicin uptake and killing in this strain were abolished by KCN (21, 24) . The decreased susceptibilities to a wide variety of aminoglycosides observed in these mutant strains suggest a more general mechanism of resistance than specific enzymatic modification or altered ribosomal binding of particular aminoglycosides. In view of data indicating that similar small-colony variants of S. aureus have impairments in oxidative processes (19, 20) and the demonstration that oxidatively generated energy is required for aminoglycoside uptake in gram-negative bacilli (4-6), we were interested in studying gentamicin accumulation and its relationship to oxidative metabolism in wild-type and aminoglycoside-resistant small-colony mutants of S. aureus.
In vitro time kill studies have demonstrated that gentamicin is rapidly bactericidal for Staphylococcus aureus; however, low concentrations of gentamicin (0.5 gg/ml) select for mutants which demonstrate increased resistance to gentamicin and other aminoglycosides and which form nonhemolytic small colonies on sheep blood agar (21) . Treatment of animals with S. aureus endocarditis with gentamicin dosages giving serum concentrations comparable to those in treated patients only minimally diminishes the bacterial densities in valvular vegetations and selects for these resistant mutants (21) . The clinical significance of dwarf-colony mutants of S. aureus is uncertain, although such mutants have been isolated occasionally from clinical material (1) . These mutants have been shown to be pathogenic when evaluated in several models of infection in animals (21, 24) . The decreased susceptibilities to a wide variety of aminoglycosides observed in these mutant strains suggest a more general mechanism of resistance than specific enzymatic modification or altered ribosomal binding of particular aminoglycosides. In view of data indicating that similar small-colony variants of S. aureus have impairments in oxidative processes (19, 20) and the demonstration that oxidatively generated energy is required for aminoglycoside uptake in gram-negative bacilli (4-6), we were interested in studying gentamicin accumulation and its relationship to oxidative metabolism in wild-type and aminoglycoside-resistant small-colony mutants of S. aureus.
(The results of this study were presented in part at the 18th Interscience Conference on An- (Table 1) . These isolates were identified by the determination of coagulase production and mannitol fermentation (21) . Several mutants resistant to gentamicin were selected in vitro with 0.5 ug of gentamicin (Schering Corp., Bloomfield, N.J.) per ml, as previously described (21 these studies was supplied by Schering Corp. The bioactivity (652/g/mg) and specific activity (637 mCi/ mmol) were confirmed by using a standard gentamicin powder (568 ,ug/mg; Schering) and a 14C standard (105 dpm; Packard). Several strains (Table 1) were unstable in broth. From these strains nonhemolytic colonies were selected from the surfaces of sheep blood agar plates after 48 to 72 h of incubation at 37°C and inoculated into NBYE. In these experiments the wildtype strains were also taken from blood agar plates. In unstable strains reversion was monitored in pour plates by noting colonial morphology and on blood agar plates by the presence or absence of hemolysis after overnight incubation (21) . Experiments in which revertants represented less than 1 in 1,000 CFU were included in the results. ['4C]gentamicin at different concentrations was added to cells in log-phase growth, and 5-ml portions were periodically sampled in duplicate by using bacterial membrane filters (0.45 ,am; Millipore Corp., Bedford, Mass.) pretreated with 1 ml of unlabeled gentamicin (250 ,ug/ml). Filtration time was less than 10 s; after filtration, filters were washed with 3% (wt/vol) NaCl, placed into counting vials, and dried overnight at 37°C. Vials were counted for 5 breaking the anaerobic system. Statistical analyses of gentamicin uptake in the presence and absence of DCCD were performed by using Student's t test; for the analysis of the association between total gentamicin accumulation and drug concentration we used the Pearson product moment correlation.
Identification of growth-stimulating factors and effect on gentamicin uptake. Mutant strains were grown and harvested from the surfaces of blood agar plates, suspended in saline, and seeded immediately onto the surfaces of Mueller-Hinton agar and blood agar plates at densities which gave confluent growth. A sterile filter paper strip saturated with gentamicin (200 ,ug/ml) was placed onto the agar of each plate. A second strip, which was saturated with one of several potential growth factors for small-colony mutants, was placed at right angles to the gentamicin strip, and plates were incubated overnight at 37°C (1).
The growth factors tested included menadione (100 ,ug/ml), fructose (100 ,g/ml), pyruvate (100 ,ug/ml), and thiamine (100 and 400 ug/ml). DCCD at a concentration of 4 mM was tested in a similar fashion.
Effect of growth factors on gentamicin uptake. Strains were preincubated for 1 to 2 h at 370C in NBYE with and without menadione (10 pg/ml), and gentamicin uptake was assayed as described above.
The effect of menadione on gentamicin uptake in S. aureus 86 
RESULTS
Gentamicin accumulation and killing studies in wild-type and mutant strains. Figure 1 shows gentamicin accumulation in two wild-type S. aureus strains and mutants derived from these strains. Gentamicin uptake in S. aureus 15956 and S. aureus 121 was rapid during the first 20 min. Thereafter, accumulation occurred at a decreasing rate, which was associated with a decrease in the rate of growth, as measured by linear absorbance. There was no significant gentamicin uptake in either S. aureus 15956 Mar or S. aureus 121 Mar. S. aureus 15956 and S. aureus 121 showed decreases of more than 2 logs (in CFU per milliliter), compared with no killing in the mutant cultures. Growth as measured by absorbance was similar for these strains during this period. The intracellular gentamicin concentration calculated for S. aureus 15956 by using a value of 1.5 ml of cell water per g (dry weight) (23) fine whether S. aureus, like gram-negative bacilli, demonstrates biphasic aminoglycoside uptake after initial aminoglycoside binding to cells (18) . Gentamicin uptake and killing in S. aureus 15956 and S. aureus 121 were biphasic (Fig. 2) after the initial binding. The duration of the first phase was shorter and the rate of uptake was more rapid with a higher gentamicin concentration (1.0 ,ug/ml) ( Fig. 2A) . Figure 2B shows that killing primarily occurred during the second, more rapid phase of gentamicin accumulation. Dose-response accumulation studies in S. aureus 121 using four concentrations of gentamicin 724 MILLER ET AL. (1.0, 2.5, 5.0, and 10 ,ig/ml) suggested concentration-dependent aminoglycoside uptake kinetics; growth was similar before the addition of gentamicin and for 30 min thereafter. The areas under the gentamicin uptake curves were determined by using the trapezoid rule (25) and were shown to be directly proportional to the concentration of gentamicin (r > +0.999) despite at least a 2-log decrease in CFU per milliliter at all concentrations.
Relationship between respiration and gentamicin accumulation and killing. To determine the requirement for oxidatively generated energy for gentamicin uptake and killing, gentamicin accumulation was measured under both aerobic and anaerobic conditions. For the anaerobic studies, the gentamicin concentration used was 15 ,ug/ml, and uptake was measured for 45 min; anaerobic broth was associated with less accumulation than was NBYE. Gentamicin uptake and killing in S. aureus 121 was noted in the aerobic flask but not in the anaerobic flask. Growth measurements as determined by linear absorbance were identical. Similarly, cells treated with 0.1% sodium azide showed marked reductions in both gentamicin uptake (1 ug/ml) and killing.
Effect of uncouplers on gentamicin accumulation and killing. Membrane energization for aminoglycoside transport was investigated further by using the uncouplers CCCP and DCCD. Gentamicin accumulation was completely inhibited by both 10 and 20 ,uM concentrations of the proton-translocating ionophore CCCP, and no diminution in cell viability was noted (Fig. 3) . Gentamicin uptake and killing were observed in the control flask which contained no CCCP. The function of membrane adenosine triphosphatase (ATPase) in the generation of energized membranes for gentamicin transport was investigated by using DCCD, which inhibits the ATPase complex in bacterial cell membranes (27) . Gentamicin uptake and killing at a DCCD concentration of 10 ,uM were identical to the uptake and killing in the control, whereas a higher DCCD concentration produced a stimulation of gentamicin uptake in each of three wild-type strains tested (Fig. 4) . This enhancement of aminoglycoside uptake was significant (P < 0.01) at 10 min. There was an associated increased rate of killing in the presence of DCCD; however, this difference was not significant. DCCD at these concentrations was not inhibitory to growth in the absence of gentamicin.
Characterization of defects and their relationship to resistance in mutant strains. An initial characterization of mutant strains was made by noting the effects of potential growth factors placed on the surfaces of agar plates or in NBYE with the mutant strains. S. aureus 15956 Mar and S. aureus 121 Mar were not stimulated with hemin, fructose, pyruvate, thiamine, or menadione. On the other hand, S. aureus 86 Mar was stimulated by menadione, and the zone of inhibition around the gentamicin strip was widened, suggesting a decrease in resistance to gentamicin. Growth stimulation was detected by noting colony size after overnight incubation. However, this strain was inhibited by concentrations of menadione of more than 12.5 ,ug/ml. A subculture of menadione-stimu- without menadione produced reversion to small nonhemolytic colonies. Gentamicin uptake in S. aureus 86 Mar was markedly increased in the presence of menadione, and uptake was associated with killing (Fig. 5A) . S. aureus 86 and S. aureus 15956 Mar were not affected by menadione. S. aureus 15956 Mar incubated with DCCD, however, showed uptake kinetics similar n 1600 k to those of S. aureus 86 Mar incubated with menadione (Fig. 5B) . In the presence of DCCD, S. aureus 15956 Mar demonstrated both gentamicin uptake and killing. To attempt to characterize the role of menadione (2-methyl-1,4-naphthoquinone) in S. aureus 86 Mar as it relates to oxidatively generated energy for aminoglycoside transport, we examined growth stimulation with related naphthoquinones. Neither menaquinone (vitamin K2), phylloquinone (vitamin K1), 1,4-naphthoquinone, nor phthiacol (2-methyl-3-hydroxy-1,4-naphthoquinone) showed any stimulation of growth. To define further the possible role of menadione in respiration, gentamicin accumulation was examined in S. aureus 86 Mar by using subinhibitory concentrations (for S. aureus 86) of KCN and DCCD. KCN inhibited gentamicin uptake and killing in S. aureus 86 Mar cells which had been preincubated with menadione (Fig. 6) . DCCD alone had a killing effect on S. aureus 86 Mar which was comparable to that with gentamicin in the presence of menadione (Fig. 7B) . However, growth of S. aureus 86 Mar with menadione (data not shown) was not inhibited by DCCD. Moreover, gentamicin uptake was normal in S. aureus 86 Mar incubated with both menadione and DCCD (Fig.  7A) . DISCUSSION Previous studies with small-colony mutants of S. aureus resistant to multiple aminoglycosideaminocycitol antibiotics suggested that this These studies have also demonstrated that gentamicin uptake in wild-type S. aureus occurs in three phases. The initial phase is virtually complete at the time that the first sample is taken and probably represents ionic adherence to the cell surface (18) . The duration and rate of the second phase are concentration dependent; the third and most rapid phase of accumulation is associated with the lethal effect of gentamicin, as determined by the inability of cells to form colonies in agar. Rapid gentamicin uptake with continued cell growth as measured by absorbance occurs during a period when most cells are acquiring a lethal amount of antibiotic. Uptake studies at multiple gentamicin concentrations have demonstrated no antibiotic inhibitory effect on those cell functions associated with aminoglycoside uptake during the early initial phases of accumulation. Anaerobic growth and sodium azide inhibit gentamicin uptake and killing, indicating that energy-dependent active drug transport requires respiration. The requirement of aerobic growth for ["4C]streptomycin uptake and killing has been reported previously in S. aureus (15) .
Membrane energization in facultative bacteria may utilize energy from respiration or adenosine 5'-triphosphate hydrolysis (12, 31) . The latter requires a functional membrane ATPase complex (2, 13, 16, 31, 34) ; both generate a proton motive force used in energy transduction for the active transport of substrates according to the chemiosmotic hypothesis of Mitchell (12, 22, 31) , The disparate effects of the uncouplers DCCD and CCCP on aminoglycoside accumulation are best explained in terms of this well-accepted model of energy transduction. The proton-translocating ionophore CCCP dissipates the membrane proton gradient and thereby uncouples respiration from adenosine 5'-triphosphate synthesis (3, 13, 17) . Inhibition of aminoglycoside uptake by CCCP in wild-type S. aureus strains suggests that a proton motive force is required for aminoglycoside uptake. A similar inhibition of aminoglycoside uptake occurs in CCCPtreated Escherichia coli cells (9) , and a naturally proton-permeable unc mutant of E. coli demonstrates increased resistance associated with reduced aminoglycoside uptake (6) . DCCD, an uncoupling agent which inactivates the ATPase complex used in the anaerobic generation of a proton motive force, did not inhibit gentamicin uptake. In fact, enhancement of uptake in wildtype S. aureus was noted when a 20 ,uM concentration of DCCD was used. Similarly, enhanced aminoglycoside uptake has been observed in a proton-impermeable unc mutant of E. coli (6); unc mutants and DCCD-treated wild-type strains are similar in that both have inactive membrane ATPase but normal redox activity.
Enhanced gentamicin uptake in the presence of DCCD (as well as in unc, proton-impermeable mutants) is consistent with the specific requirement for respiration for the generation of a proton motive force used for aminoglycoside uptake. According to the chemiosmotic view of energy transduction, the energy derived from proton extrusion which is related to respiration is nornally coupled to and thus partially dissi-VOL. 18, 1980 on June 27, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AGENTS CHEMOTHER.
pated by adenosine 5'-triphosphate synthesis via the membrane ATPase complex. Therefore, strains with an inactive membrane ATPase complex would be expected to have enhanced aerobic membrane energization for aminoglycoside uptake. The inability of facultative bacteria to utilize an anaerobically generated proton motive force suggests that either anaerobic growth is associated with insufficient membrane energization for aminoglycoside uptake or a carrier system coupled to respiration is required for the transport of hydrophilic aminoglycosides across bacterial cell membranes (6) .
Resistance in small-colony mutants of S. aureus appears to be due to a failure to accumulate gentamicin intracellularly. This resistance is not due to a diminished rate of growth. Several classes of Mar mutants have been identified. One strain, S. aureus 86 Mar, showed both growth stimulation and gentamicin accumulation in the presence of menadione. The lethal effect of DCCD on S. aureus 86 Mar but not on S. aureus 86 or S. aureus 15956 Mar suggested that the former was a respiratory auxotroph which required a functional ATPase to provide energization for normal growth. The DCCD-induced lethal effect on S. aureus 86 Mar was prevented by supplementation with menadione. With menadione supplementation normal gentamicin accumulation occurred with or without exposure to DCCD. These observations, in conjunction with the observation that KCN inhibited gentamicin uptake in S. aureus 86 Mar incubated with menadione, suggest that menadione or a related compound functions in the respiration associated with membrane energization for gentamicin uptake. Menaquinone, the primary naturally occurring naphthoquinone in S. aureus, and benzoquinones, such as ubiquinone, function in electron transport in bacteria (7, 8, 11, 29, 32) . Menadione in staphylococci acts as a precursor to menaquinone or related naphthoquinones (14, 30) and is found in S. aureus cell membranes (17) .
Another small-colony mutant, S. aureus 15956 Mar, failed to show growth stimulation or alteration of gentamicin susceptibility when incubated with hemin, fructose, pyruvate, thiamine, or menadione. Growth of this mutant in the presence of DCCD was associated with normal gentamicin uptake and killing, indicating that this strain has a different defect and that it may be relatively proton permeable and thus unable to energize membranes for aminoglycoside transport (2, 12, (26) (27) (28) . A third class ofS. aureus small-colony mutants has been reported, which is selected with aminoglycosides and is stimulated by heme (19) . Slow-growing small-colony mutants of Bacillus subtilis which are cytochrome and respiration deficient demonstrate both increased resistance to kanamycin and decreased drug uptake (33); a similar mechanism of resistance seems likely in heme mutants of S.
aureus.
